We announced today, June 19, 2008, the signing of a Service Contract with the University of British Columbia to conduct research on the treatment of Mycobacterium tuberculosis (“TB”), with nitric oxide, utilizing the patented nitric oxide generator and the proprietary nitric oxide generating tablets manufactured by us.  This Service Contract lasts for one year.  See the Press Release, Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Description

Exhibit No.

99.1 Press Release

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

GeNOsys, INC.

Date: 6/19/2008

By/s/John W. R. Miller

President and director